Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
icosapent ethyl (vascepa) (1 trial)
vitamin a (1 trial)
vitamin d3 (1 trial)
vitamin e (1 trial)
Dry Eye Syndromes (Phase 4)
Keratoconjunctivitis Sicca (Phase 4)
Trials (1 total)
Trial APIs (4 total)